Literature DB >> 9563373

Relative safety and efficacy of inhaled corticosteroids.

N Barnes1.   

Abstract

Inhaled corticosteroids are the main treatment for controlling asthma in adults and children. However, there is still some concern over the safety of these drugs when used at high doses and for long periods of time. Hence issues relating to the efficacy and safety of inhaled corticosteroids have been extensively researched over the past 5 years. General considerations, such as use of an appropriate dose of inhaled corticosteroid in an appropriate asthma population, are discussed. Studies comparing the efficacy and safety of fluticasone propionate, beclomethasone dipropionate, and budesonide are highlighted, and a systematic review of these studies suggests that fluticasone propionate has a better efficacy:safety therapeutic ratio than either beclomethasone dipropionate or budesonide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563373     DOI: 10.1016/s0091-6749(98)70160-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study.

Authors:  K J Mortimer; L J Tata; C J P Smith; J West; T W Harrison; A E Tattersfield; R B Hubbard
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

2.  Fluticasone Induces Epithelial Injury and Alters Barrier Function in Normal Subjects.

Authors:  Ruth E MacRedmond; Gurpreet K Singhera; Samuel J Wadsworth; Susan Attridge; Mohammed Bahzad; Kristy Williams; Harvey O Coxson; Steven R White; Delbert R Dorscheid
Journal:  J Steroids Horm Sci       Date:  2014-06-11

3.  Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma.

Authors:  Alessandra Scaparrotta; Sabrina Di Pillo; Marina Attanasi; Daniele Rapino; Anna Cingolani; Nicola Pietro Consilvio; Marcello Verini; Francesco Chiarelli
Journal:  Multidiscip Respir Med       Date:  2012-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.